VKH
BLPH

Virtu KCG Holdings’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Virtu KCG Holdings’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$14K Buy
+675
New +$14K ﹤0.01% 2757
2017
Q1 		– Sell
-773
Closed -$6K – 4009
2016
Q4 		$6K Sell
773
-1,386
-64% -$19.3K ﹤0.01% 3323
2016
Q3 		$45K Buy
2,159
+1,070
+98% +$25.8K ﹤0.01% 2808
2016
Q2 		$29K Buy
+1,089
New +$29.9K ﹤0.01% 2757

Other funds holding BLPH

NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's BLPH Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Bellerophon Therapeutics, Inc. (BLPH) in Q2 2017: 675 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #2757 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in BLPH as recently as Q4 2016.

Virtu KCG Holdings first reported a position in BLPH in Q2 2016 and has held it in 4 quarters since. The position peaked at $45K in Q3 2016. 20 funds tracked by Wall St. Rank hold BLPH as of Q2 2017.

  • Virtu KCG Holdings held 675 shares of Bellerophon Therapeutics, Inc. worth $14K as of Q2 2017.
  • Bellerophon Therapeutics, Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Bellerophon Therapeutics, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2757 holding.
  • Virtu KCG Holdings first reported a position in Bellerophon Therapeutics, Inc. in Q2 2016 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Bellerophon Therapeutics, Inc. position peaked at $45K in Q3 2016.
  • 20 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.